Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from SciELO through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

The impact of interleukin-13 receptor expressions in cell migration of astrocytomas

Full text
Author(s):
Isabele Fattori Moretti [1] ; Roseli Silva [2] ; Sueli Mieko Oba-Shinjo [3] ; Priscila Oliveira de Carvalho [4] ; Lais Cavalca Cardoso [5] ; Isac de Castro [6] ; Suely Kazue Nagahashi Marie
Total Authors: 7
Affiliation:
[1] Universidade de São Paulo. Faculdade de Medicina. Departamento de Neurologia - Brasil
[2] Universidade de São Paulo. Faculdade de Medicina. Departamento de Neurologia - Brasil
[3] Universidade de São Paulo. Faculdade de Medicina. Departamento de Neurologia - Brasil
[4] Universidade de São Paulo. Faculdade de Medicina. Departamento de Neurologia - Brasil
[5] Universidade de São Paulo. Faculdade de Medicina. Departamento de Neurologia - Brasil
[6] Universidade de São Paulo. Faculdade de Medicina. Departamento de Clínica Médica - Brasil
Total Affiliations: 7
Document type: Journal article
Source: MedicalExpress (São Paulo, online); v. 2, n. 5 2015-10-00.
Abstract

INTRODUCTION: Astrocytomas are common brain tumors. Increased expression levels of Interleukin-13 Receptor α2 (IL-13RA2) have been reported in astrocytomas. The Interleukin-13 signaling pathway may be associated with cell migration when binding to Interleukin-13 Receptor α1. OBJECTIVE: To investigate Interleukin-13 Receptor α1 (IL-13RA1) and IL13RA2 expression levels in human diffusely infiltrative astrocytomas and test the involvement of Interleukin-13 levels in cell migration in two glioblastoma cell lines. METHODS: IL13RA expression levels were accessed by quantitative real time PCR in 128 samples of astrocytomas and 18 samples of non-neoplastic brain tissues from temporal lobe epilepsy surgery. The impact of IL-13 levels (10 and 20 ng/mL) on cell migration was analyzed by the wound assay in U87MG and A172 cells. RESULTS: Glioblastoma presented higher IL13RA1 and IL13RA2 expression levels compared to lower grades astrocytomas and to non-neoplastic cases. U87MG and A172 cells presented higher expression levels of IL-13RA1 vs. IL-13RA2. A significant difference in migration rate was observed in A172 cells treated with 10 ng/mL of IL-13 vs. control: treated cells presented slower migration than non-treated cells. U87MG cells treated with IL-13 20ng/mL presented slower migration than non-treated cells. This indicates that the IL13Rα1 signaling pathway was not activated, indeed inhibited by the decoy IL-13Rα2, slowing cell migration. This impact occurred with a lesser concentration of IL-13 on the A172 than on the U87MG cell line, because A172 cells have a higher IL-13RA2/A1 ratio. CONCLUSION: The present results suggest IL-13 receptors as possible targets to decrease tumor cell migration. (AU)

FAPESP's process: 13/06315-3 - The role of microglia activation in human astrocytoma
Grantee:Suely Kazue Nagahashi Marie
Support Opportunities: Regular Research Grants
FAPESP's process: 13/02162-8 - Molecular pathogenesis and characterization of monogenic developmental diseases: a route to translational medicine
Grantee:Berenice Bilharinho de Mendonça
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 04/12133-6 - Search for molecular markers related to the diagnosis and prognosis of tumors of the central nervous system
Grantee:Suely Kazue Nagahashi Marie
Support Opportunities: Research Projects - Thematic Grants